Abstract
The gene LMNA encodes the proteins lamins A and C and is implicated in nine different laminopathies — inherited diseases that are linked to premature ageing. Recent evidence has demonstrated that lamins A and C have essential functions in protecting cells from physical damage, as well as in maintaining the function of transcription factors required for the differentiation of adult stem cells. Thus, the degenerative nature of laminopathies is explained because these lamins are essential for maintenance of somatic tissues in adulthood.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fisher, D., Chaudhary, N. & Blobel, G. cDNA sequencing of nuclear lamins A and C reveals primary and secondary structure homology to intermediate filament proteins. Proc. Natl Acad. Sci. USA 83, 6450–6454 (1986).
McKeon, F., Kirschner, M. & Caput, D. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 319, 407–414 (1986).
Frangioni, J. & Neel, B. Use of a general purpose mammalian expression vector for studying intracellular protein targeting: identification of critical residues in the nuclear lamin A/C nuclear localisation sequence. J. Cell Sci. 105, 481–488 (1993).
Holtz, D., Tanaka, R., Hartwig, J. & McKeon, F. The CaaX motif of lamin A functions in conjunction with the nuclear localisation signal to target assembly of the nuclear envelope. Cell 59, 969–977 (1989).
Krohne, G., Waisenegger, I. & Hoger, T. The conserved carboxyl-terminal cysteine of nuclear lamins is essential for lamin association with the nuclear envelope. J. Cell Biol. 109, 2003–2011 (1989).
Vorburger, K., Kitten, G. T. & Nigg, E. A. Modification of nuclear lamin proteins by a mevalonic acid derivative occurs in reticulocyte lysates and requires the cysteine residue of the C-terminal CxxM motif. EMBO J. 8, 4007–4013 (1989).
Aebi, U., Cohn, J., Buhle, L. & Gerace, L. The nuclear lamina is a meshwork of intermediate filament type filaments. Nature 323, 560–564 (1986).
Hutchison, C. J., Alvarez-Reyes, M. & Vaughan, O. A. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue specific disease phenotypes? J. Cell Sci. 114, 9–19 (2001).
Harborth, J., Elbashir, S. M., Bechert, K., Tuschl, T. & Weber, K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114, 4557–4565 (2001).
Johnson, B. R. et al. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteosomal degradation. Proc. Natl Acad. Sci. USA 101, 9677–9682 (2004).
Hutchison, C. J. Lamins: building blocks or regulators of gene expression? Nature Rev. Mol. Cell Biol. 3, 848–858 (2002).
Newport, J., Wilson, K. L. & Dunphy, W. A lamin independent pathway for nuclear envelope assembly. J. Cell Biol. 111, 2247–2259 (1990).
Meier, J., Campbel, K. H. S., Ford, C. C., Stick, R. & Hutchison, C. J. The role of lamin Liii in nuclear assembly and DNA replication, in cell-free extracts of Xenopus eggs. J. Cell Sci. 98, 271–279 (1991).
Ellis, D. J., Jenkins, H. E., Whitfield, W. G. & Hutchison, C. J. GST–lamin fusion proteins act as dominant negative mutants in Xenopus egg extracts and reveal the function of the lamina in DNA replication. J. Cell Sci. 110, 2507–2518 (1997).
Spann, T. P., Moir, R. D., Goldman, A. E., Stick, R. & Goldman, R. D. Disruption of nuclear lamin organization alters the distribution of replication factors and inhibits DNA synthesis. J. Cell Biol. 136, 1201–1212 (1997).
Lui, J. et al. Essential roles of Caenorhabditis elegans lamin gene in nuclear organisation, cell cycle progression, and spatial organization of nuclear pore complexes. Mol. Biol. Cell 11, 3937–3947 (2000).
Furukawa, K. & Hotta, Y. cDNA cloning of a germ cell specific lamin B3 from mouse spermatocytes and analysis of its function by ectopic expression in somatic cells. EMBO J. 12, 97–106 (1993).
Schirmer, E., Guam, T. & Gerace, L. Involvement of the lamin rod domain in heterotypic lamin interactions important for nuclear organisation. J. Cell Biol. 153, 479–489 (2001).
Zhang, Q. et al. Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues. J. Cell Sci. 114, 4485–4498 (2001).
Zhen, Y.-Y., Libotte, T., Munck, M., Noegal, A. A. & Korenbaum, E. NUANCE: a giant protein connecting the nucleus and actin cytoskeleton. J. Cell Sci. 115, 3207–3222 (2002).
Apel, E. D., Lewis, R. M., Grady, R. M. & Sanes, J. R. Syne-1, a dystrophin- and Klarsicht-related protein associated with synaptic nuclei at the neuromuscular junction. J. Biol. Chem. 275, 31986–31995 (2002).
Mislow, J. et al. Nesprin-1α self-associates and binds directly to emerin and lamin A in vitro. FEBS Lett. 525, 135–140 (2002).
Muchir, A. et al. Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene. Exp. Cell Res. 291, 352–362 (2003).
Vaughan, O. A. et al. Lamins A and C form a structural complex that anchors emerinat the nuclear envelope. J. Cell Sci. 114, 2577–2590 (2001).
Sullivan, T. et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147, 913–920 (1999).
Bengtsson, L. & Wilson, K. L. Multiple and surprising new functions for emerin, a nuclear membrane protein. Curr. Opin. Cell Biol. 16, 73–79 (2004).
Maatta, A., Hutchison, C. J. & Watson, M. D. in The Nuclear Envelope (eds Evans, D. E., Hutchison, C. J. & Bryant, J. A.) SEB Symposium Series 56, 265–278 (2004).
Inbger, D. E. Mechanosensation through integrins: cells act locally but think globally. Proc. Natl Acad. Sci. USA 100, 1472–1474 (2003).
Lammerding, J. et al. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J. Clin. Invest. 113, 370–378 (2004).
Broers, J. V. L. et al. Decreased mechanical stiffness in LMNA−/− cells is caused by defective nucleo-cytoskeletal integrity. Implications for the development of laminopathies. Hum. Mol. Genet. (in the press).
Spann, T. P., Goldman, A. E., Wang, C., Huang, S. & Goldman, R. D. Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent transcription. J. Cell Biol. 156, 603–608 (2002).
Imai, S. et al. Dissociation of Oct-1 from the nuclear peripheral structures induces the cellular aging-associated collagenase gene expression. Mol. Biol. Cell 8, 2407–2419 (1997).
Nili, E. et al. Nuclear membrane protein LAP2β, mediates transcriptional repression alone and together with its binding partner GCL (germ cell-less). J. Cell Sci. 114, 3297–3307 (2001).
Jagatheesan, G. et al. Co-localization of intranuclear lamin foci with RNA splicing factors. J. Cell Sci. 112, 4651–4661 (1999).
Kennedy, B. K., Barbie, D. A., Classon, M., Dyson, N. & Harlow, E. Nuclear organization of DNA replication in primary mammalian cells. Genes Dev. 14, 2855–2868 (2000).
Muralikrishna, B., Dhawan, J., Rangaraj, N. & Parnaik, V. K. Distinct changes in intranuclear lamin A/C organization during myoblast differentiation. J. Cell Sci. 114, 4001–4011 (2001).
Ozaki, T. et al. Complex formation between lamin A and the retinoblastoma gene product: Identification of the domain on lamin A required for its interaction. Oncogene 9, 2649–2653 (1994).
Lloyd, D. J., Trembath, R. C. & Shackleton, S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum. Mol. Genet. 11, 769–777 (2002).
Dreuillet, C., Tillit, J., Kress, M. & Ernoult-Lange, M. In vivo and in vitro interaction between human transcription factor MOK2 and nuclear lamin A/C. Nucleic Acids Res. 30, 4634–4642 (2002).
Holaska, J. M., Lee, K. K., Kowalski, A. K. & Wilson, K. L. Transcription repressor germ cell-less (GCL) and barrier to autointegration factor (BAF) compete for binding to emerin in vitro. J. Biol. Chem. 278, 6969–6975 (2003).
Stierlé, V. et al. The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. Biochemistry 42, 4819–4828 (2003).
Markiewicz, E., Dechat, T., Foisner, R., Quinlan, R. A. & Hutchison, C. J. Lamin A/C binding protein LAP2α is required for nuclear anchorage of retinoblastoma protein. Mol. Biol. Cell 13, 4401–4413 (2002).
Hinds, P. W. et al. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993–1006 (1992).
Bione, S. et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nature Genet. 8, 323–327 (1994).
Emery, A. E. & Dreifuss, F. E. Unusual type of benign X-linked muscular dystrophy. J. Neurol. Neurosurg. Psychiatry 29, 338–342 (1966).
Nagano, A. et al. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nature Genet. 12, 254–259 (1996).
Manilal, S., Nguyen, T. M., Sewry, C. A. & Morris, G. E. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum. Mol. Genet. 5, 801–808 (1996).
Clements, L., Manilal, S., Love, D. R. & Morris, G. E. Direct interaction between emerin and lamin A. Biochem. Biophys. Res. Commun. 267, 709–714 (2000).
Bonne, G. et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nature Genet. 21, 285–288 (1999).
Fatkin, D. et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med. 341, 1715–1724 (1999).
Muchir, A. et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 9, 1453–1459 (2000).
Lin, F. & Worman, H. J. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J. Biol. Chem. 268, 16321–16326 (1993).
Bonne, G. et al. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann. Neurol. 48, 170–180 (2000).
Dunnigan, M. G., Cochrane, M. A., Kelly, A. & Scott, J. W. Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q. J. Med. 43, 33–48 (1974).
Grundy, S. M. et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler. Thromb. Vasc. Biol. 24, e13–e18 (2004).
Peters, J. M. et al. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21–22. Nature Genet. 18, 292–295 (1998).
Wydner, K. L., McNeil, J. A., Lin, F., Worman, H. J. & Lawrence, J. B. Chromosomal assignment of human nuclear envelope protein genes LMNA, LMNB1, and LBR by fluorescence in situ hybridization. Genomics 32, 474–478 (1996).
Cao, H. & Hegele, R. A. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9, 109–112 (2000).
Shackleton, S. et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nature Genet. 24, 153–156 (2000).
Speckman, R. A. et al. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am. J. Hum. Genet. 66, 1192–1198 (2000).
Dhe-Paganon, S., Werner, E. D., Chi, Y. I. & Shoelson, S. E. Structure of the globular tail of nuclear lamin. J. Biol. Chem. 277, 17381–17384 (2002).
Krimm, I. et al. The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure 10, 811–823 (2002).
Cutler, D. A., Sullivan, T., Marcus-Samuels, B., Stewart, C. L. & Reitman, M. L. Characterization of adiposity and metabolism in Lmna-deficient mice. Biochem. Biophys. Res. Commun. 291, 522–527 (2002).
De Sandre-Giovannoli, A. et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 70, 726–736 (2002).
Novelli, G. et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am. J. Hum. Genet. 71, 426–431 (2002).
Agarwal, A. K., Fryns, J. P., Auchus, R. J. & Garg, A. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum. Mol. Genet. 12, 1995–2001 (2003).
Bergo, M. O. et al. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc. Natl Acad. Sci. USA 99, 13049–13054 (2002).
Pendas, A. M. et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nature Genet. 31, 94–99 (2002).
Navarro, C. et al. Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum. Mol. Genet. 13, 2493–503 (2004).
Caux, F. et al. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J. Clin. Endocrinol. Metab. 88, 1006–1013 (2003).
DeBusk, F. L. The Hutchinson-Gilford progeria syndrome. J. Pediatr. 80, 697–724 (1972).
Eriksson, M. et al. Recurrent de novo point mutations in lamin A cause Hutchinson- Gilford progeria syndrome. Nature 423, 293–298 (2003).
De Sandre-Giovannoli, A. et al. Lamin A truncation in Hutchinson-Gilford progeria. Science 300, 2055 (2003).
Cao, H. & Hegele, R. A. LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090). J. Hum. Genet. 48, 271–274 (2003).
Mounkes, L. C., Kozlov, S., Hernandez, L., Sullivan, T. & Stewart, C. L. A progeroid syndrome in mice is caused by defects in A-type lamins. Nature 423, 298–301 (2003).
Chen, L. et al. LMNA mutations in atypical Werner's syndrome. Lancet 362, 440–445 (2003).
Csoka, A. B. et al. Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J. Med. Genet. 41, 304–308 (2004).
Worman, H. J. & Courvalin, J.-C. The nuclear lamina and inherited disease. Trends Cell Biol. 12, 591–598 (2002).
Cohen, M., Lee, K. K., Wilson, K. L. & Gruenbaum, Y. Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem. Sci. 26, 41–48 (2001).
Wilson, K. L., Zastro, M. S. & Lee, K. K. Lamins and disease: insights into nuclear infrastructure. Cell 104, 647–650 (2001).
Nikolova, V. et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J. Clin. Invest. 113, 357–369 (2004).
Östlund, C., Bonne, G., Schwartz, K. & Worman, H. J. Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. J. Cell Sci. 114, 4435–4445 (2001).
Raharjo, W. H., Enarson, P., Sullivan, T., Stewart, C. L. & Burke, B. Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. J. Cell Sci. 114, 4447–4457 (2001).
Goldman, R. D. et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc. Natl Acad. Sci. USA 101, 8963–8968 (2004).
Bridger, J. M. & Kill, I. R. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp. Gerontol. 39, 717–724 (2004).
Vigoroux, C., et al. Nuclear disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. J. Cell Sci. 114, 4459–4468 (2001).
Muchir, A. et al. Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy and partial lipodystrophy carrying lamin A/C gene mutations. Muscle Nerve 30, 444–450 (2004).
Fidzianska, A., Toniolo, D. & Hausmaowa-Petrusewicz . Ultrastructural abnormality of sarcolemmal nuclei in Emery-Dreifuss muscular dystrophy (EDMD). J. Neurol. Sci. 159, 88–93 (1998).
Fidzianska, A. & Hausmanowa-Petrusewicz, I. Architectural abnormalities in muscle nuclei. Ultrastructural differences between X-linked and autosomal dominant forms of EDMD. J. Neurol. Sci. 210, 47–51 (2003).
Markiewicz, E., et al. Increased solubility of lamins and redistribution of lamin C in X-linked Emery-Dreifuss muscular dystrophy fibroblasts. J. Struct. Biol. 140, 241–253 (2002).
Novitch, B. G., Spicer, D. B., Kim, P. S., Cheung, W. L. & Lassar, A. B. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 9, 449–459 (1999).
Hansen, J. B. et al. Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc. Natl Acad. Sci. USA 101, 4112–4117 (2004).
Favreau, C., Higuet, D., Courvalin, J.-C. & Buendia, B. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol. Cell. Biol. 24, 1481–1892 (2004).
Markiewicz, E., Ledran, M. & Hutchison, C. J. Remodelling of the nuclear lamina and nucleoskeleton is required for skeletal muscle differentiation in vitro. J. Cell Sci (in the press).
Acknowledgements
C.J.H. is supported by grants from the Association for International Cancer Research, the Muscular Dystrophy Campaign and the Wellcome Trust. H.J.W. is supported by the National Institutes of Health, the Muscular Dystrophy Association and the American Diabetes Association.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hutchison, C., Worman, H. A-type lamins: Guardians of the soma?. Nat Cell Biol 6, 1062–1067 (2004). https://doi.org/10.1038/ncb1104-1062
Issue Date:
DOI: https://doi.org/10.1038/ncb1104-1062